Table 2 Clinicopathological characteristics in the patients with or without sarcopenia
|  | Sarcopenia (N = 68) | Non sarcopenia (N = 104) | p value |
|---|---|---|---|
Age, mean ± SD | 51.8 ± 12.2 | 51.2 ± 11.3 | 0.729 |
Gender, N (%) | Â | Â | 0.002 |
 Male | 52(76.5) | 97(93.3) |  |
 Female | 16(23.5) | 7(6.7) |  |
Body mass index (kg/m2), median (IQR) | 20.5(18.3–24.2) | 22.7(21.0–24.2) | 0.002 |
Viral status, N (%) | Â | Â | 0.036 |
 HCV | 1(1.5) | 2(1.9) |  |
 HBV | 56(82.3) | 95(91.4) |  |
 HCV + HBV | 0(0.0) | 2(1.9) |  |
 None | 11(16.2) | 5(4.8) |  |
Alcohol consumption, N (%) | Â | Â | 0.452 |
  > 80 g per day | 6(8.8) | 13(12.5) |  |
Smoking status, N (%) | Â | Â | 0.261 |
 Never | 45(66.2) | 56(53.9) |  |
 former | 7(10.3) | 12(11.5) |  |
 current | 16(23.5) | 36(34.6) |  |
BCLC stage, N (%) | Â | Â | 0.392 |
 B | 12(17.6) | 24(23.1) |  |
 C | 56(82.4) | 80(76.9) |  |
ECOG-PS, N (%) | Â | Â | 0.594 |
 0 | 33(48.5) | 59(56.7) |  |
 1 | 29(42.7) | 39(37.5) |  |
 2 | 4(5.9) | 5(4.8) |  |
 3 | 2(2.9) | 1(1.0) |  |
Child-Pugh Class, N (%) | Â | Â | 0.266 |
 A | 54(79.4) | 84(80.8) |  |
 B | 12(17.7) | 20(19.2) |  |
 C | 2(2.9) | 0(0.0) |  |
Comorbidity, N (%) | |||
 Hypertension (yes/no) | 17/51(25.0/75.0) | 18/86(17.3/82.7) | 0.221 |
 Diabetes (yes/no) | 10/58(14.7/85.3) | 10/94(9.6/90.4) | 0.309 |
 Liver Cirrhosis (yes/no) | 33/35(48.5/51.5) | 69/35(66.3/33.7) | 0.020 |
Previous treatment (yes/no), N (%) | 60/8(88.2/11.8) | 94/10(90.4/9.6) | 0.653 |
Baseline metastasis (yes/no), N (%) | 59/9(86.8/13.2) | 76/28(73.1/26.9) | 0.033 |